BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND MALAT1, PRO1073, 378938, Q9UHZ2
56 results:

  • 1. Comparative genomics incorporating translocation renal cell carcinoma mouse model reveals molecular mechanisms of tumorigenesis.
    Prakasam G; Mishra A; Christie A; Miyata J; Carrillo D; Tcheuyap VT; Ye H; Do QN; Wang Y; Reig Torras O; Butti R; Zhong H; Gagan J; Jones KB; Carroll TJ; Modrusan Z; Durinck S; Requena-Komuro MC; Williams NS; Pedrosa I; Wang T; Rakheja D; Kapur P; Brugarolas J
    J Clin Invest; 2024 Feb; 134(7):. PubMed ID: 38386415
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. METTL3-modified lncRNA-malat1 regulates the molecular axis of miR-124-3p/CDK4 involved in Ewing's sarcoma.
    He F; Ren T; Tang X
    Cell Mol Biol (Noisy-le-grand); 2023 Jun; 69(6):193-197. PubMed ID: 37605570
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Bioinformatics Identification and Validation of Aging‑Related Molecular Subtype and Prognostic Signature in Sarcoma.
    Hong X; Liu H; Chen C; Lai T; Lin J
    Cancer Invest; 2023 May; 41(5):512-523. PubMed ID: 37130077
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. IncRNA malat1 Regulates the Proliferation, Apoptosis, Migration, and Invasion of Osteosarcoma Cells by Targeting miR-873-5p/ROCK1.
    Yang F; Wang M; Shi J; Xu G
    Crit Rev Eukaryot Gene Expr; 2023; 33(2):67-79. PubMed ID: 36734858
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Regulation of the Key Epithelial Cancer Suppressor miR-124 Function by Competing Endogenous RNAs.
    Braga EA; Fridman MV; Burdennyy AM; Filippova EA; Loginov VI; Pronina IV; Dmitriev AA; Kushlinskii NE
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362406
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Transcriptome analysis identifies TODL as a novel lncRNA associated with proliferation, differentiation, and tumorigenesis in liposarcoma through FOXM1.
    Kanojia D; Kirtonia A; Srujana NSV; Jeevanandan SP; Shyamsunder P; Sampath SS; Dakle P; Mayakonda A; Kaur H; Yanyi J; Koeffler HP; Garg M
    Pharmacol Res; 2022 Nov; 185():106462. PubMed ID: 36167276
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. LncRNA malat1-related signaling pathways in osteosarcoma.
    Farzaneh M; Najafi S; Anbiyaee O; Azizidoost S; Khoshnam SE
    Clin Transl Oncol; 2023 Jan; 25(1):21-32. PubMed ID: 35790599
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Allicin Inhibits Osteosarcoma Growth by Promoting Oxidative Stress and Autophagy via the Inactivation of the lncRNA malat1-miR-376a-Wnt/
    Xie W; Chang W; Wang X; Liu F; Wang X; Yuan D; Zhang Y
    Oxid Med Cell Longev; 2022; 2022():4857814. PubMed ID: 35783190
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The microRNA-202 as a Diagnostic Biomarker and a Potential Tumor Suppressor.
    Ahmed EA; Rajendran P; Scherthan H
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682549
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Establishment and application of a human osteosarcoma U-2OS cell line that can stably express Cas9 protein.
    Zhou Y; Li Y; Zhang Y; Yi Z; Jiang M
    Mol Cell Biochem; 2022 Sep; 477(9):2183-2191. PubMed ID: 35445373
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The emerging role of lncRNAs in the regulation of osteosarcoma stem cells.
    Song XJ; Bi MC; Zhu QS; Liu XL
    Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):966-974. PubMed ID: 35179763
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A review of neoplasms with MITF/MiT family translocations.
    Wei S; Testa JR; Argani P
    Histol Histopathol; 2022 Apr; 37(4):311-321. PubMed ID: 35107169
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Dynamic bulge nucleotides in the KSHV PAN ENE triple helix provide a unique binding platform for small molecule ligands.
    Swain M; Ageeli AA; Kasprzak WK; Li M; Miller JT; Sztuba-Solinska J; Schneekloth JS; Koirala D; Piccirili J; Fraboni AJ; Murelli RP; Wlodawer A; Shapiro BA; Baird N; Le Grice SFJ
    Nucleic Acids Res; 2021 Dec; 49(22):13179-13193. PubMed ID: 34871450
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. LncRNAs and miRNAs participate in determination of sensitivity of cancer cells to cisplatin.
    Taheri M; Shoorei H; Tondro Anamag F; Ghafouri-Fard S; Dinger ME
    Exp Mol Pathol; 2021 Dec; 123():104602. PubMed ID: 33422487
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. miR-485-3p regulated by malat1 inhibits osteosarcoma glycolysis and metastasis by directly suppressing c-MET and AKT3/mTOR signalling.
    Wang Q; Liu MJ; Bu J; Deng JL; Jiang BY; Jiang LD; He XJ
    Life Sci; 2021 Mar; 268():118925. PubMed ID: 33358903
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Long Non-Coding RNAs as Competitive Endogenous RNAs in Osteosarcoma].
    Kushlinskii NE; Fridman MV; Braga EA
    Mol Biol (Mosk); 2020; 54(5):776-801. PubMed ID: 33009789
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Exercise-mediated downregulation of malat1 expression and implications in primary and secondary cancer prevention.
    Paronetto MP; Dimauro I; Grazioli E; Palombo R; Guidotti F; Fantini C; Sgrò P; De Francesco D; Di Luigi L; Capranica L; Caporossi D
    Free Radic Biol Med; 2020 Nov; 160():28-39. PubMed ID: 32768573
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. LncRNA malat1 facilitates lung metastasis of osteosarcomas through miR-202 sponging.
    Zhang J; Piao CD; Ding J; Li ZW
    Sci Rep; 2020 Jul; 10(1):12757. PubMed ID: 32728178
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Long noncoding RNAs in osteosarcoma via various signaling pathways.
    Han J; Shen X
    J Clin Lab Anal; 2020 Jun; 34(6):e23317. PubMed ID: 32249459
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A Malignant Neoplasm From the Jejunum With a
    Prall OWJ; McEvoy CRE; Byrne DJ; Iravani A; Browning J; Choong DY; Yellapu B; O'Haire S; Smith K; Luen SJ; Mitchell PLR; Desai J; Fox SB; Fellowes A; Xu H
    Int J Surg Pathol; 2020 Aug; 28(5):553-562. PubMed ID: 31931637
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.